Literature DB >> 17253146

Women's views of their sexual difficulties: agreement and disagreement with clinical diagnoses.

Michael King1, Victoria Holt, Irwin Nazareth.   

Abstract

There is controversy about how to conceptualize sexual problems in women. Our purpose in this study was to compare ICD-10 diagnoses of sexual dysfunction in women with whether or not the woman perceived she had a sexual problem, her views on its origins, and its impact on her life. Participants (N = 401, M age, 37.8 years) were consecutive attendees to general practices in London, England. Our main measures were an ICD-10 diagnosis of sexual dysfunction and the woman's own perception of a sexual problem. Based on reported symptoms and behavior, 38% of women had at least one ICD-10 diagnosis of sexual dysfunction. Prevalence fell to 18% in women who also perceived they had a problem and to 6% in women who regarded the problem as moderate or severe. A total of 73 (18%) women were assigned an ICD-10 diagnosis and agreed that they had a problem, 80 (20%) were assigned a diagnosis but reported no problem, 78 (19%) had no diagnosis but reported a sexual problem, and 170 (42%) had no diagnosis and reported no problem. For women with sexual partners, reported sexual satisfaction was lowest in those assigned an ICD-10 diagnosis who also perceived they had a problem and highest in those with no diagnosis and no perceived problem. Relationship and emotional difficulties were the most common perceived causes of sexual difficulties, whether or not an ICD-10 diagnosis was assigned. There were three aspects to sexual difficulties in women. The first concerned symptoms and behavior that clinicians used to make a diagnosis, the second was the woman's own perception that she had a sexual difficulty, and the third was her level of sexual satisfaction. All three appear to be important and may explain why published prevalence rates of sexual dysfunction and associated factors are so conflicting.

Entities:  

Mesh:

Year:  2007        PMID: 17253146     DOI: 10.1007/s10508-006-9090-y

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  8 in total

Review 1.  Impact of Antidepressant Drugs on Sexual Function and Satisfaction.

Authors:  David S Baldwin; Chris Manson; Magda Nowak
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

2.  Why is impaired sexual function distressing to women? The primacy of pleasure in female sexual dysfunction.

Authors:  Kyle R Stephenson; Cindy M Meston
Journal:  J Sex Med       Date:  2014-12-29       Impact factor: 3.802

3.  When are sexual difficulties distressing for women? The selective protective value of intimate relationships.

Authors:  Kyle R Stephenson; Cindy M Meston
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

4.  The association between sexual motives and sexual satisfaction: gender differences and categorical comparisons.

Authors:  Kyle R Stephenson; Tierney K Ahrold; Cindy M Meston
Journal:  Arch Sex Behav       Date:  2010-10-22

5.  The association between sexual satisfaction and body image in women.

Authors:  Yasisca Pujols; Brooke N Seal; Cindy M Meston
Journal:  J Sex Med       Date:  2009-11-24       Impact factor: 3.802

6.  Incidence of sexual dysfunction: a prospective survey in Ghanaian females.

Authors:  Nafiu Amidu; William K B A Owiredu; Eric Woode; Otchere Addai-Mensah; Lawrence Quaye; Abass Alhassan; Edmond A Tagoe
Journal:  Reprod Biol Endocrinol       Date:  2010-09-01       Impact factor: 5.211

7.  Pathways to help-seeking for sexual difficulties in older adults: qualitative findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).

Authors:  Sharron Hinchliff; Ruth Lewis; Kaye Wellings; Jessica Datta; Kirstin Mitchell
Journal:  Age Ageing       Date:  2021-02-26       Impact factor: 12.782

8.  Transition stages in adjustment of wives with their husbands' erectile dysfunction.

Authors:  Giti Ozgoli; Saeideh Ziaei; Fazlollah Ahmadi; Mahyar Azar
Journal:  Iran Red Crescent Med J       Date:  2014-03-05       Impact factor: 0.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.